Screener
Rapport Therapeutics, Inc.
RAPPRapport Therapeutics is a clinical-stage biotechnology company focused on developing small molecule precision medicines for neurological and psychiatric disorders.
Earnings
Next report
Nov 5, 2026 (in 3 months)EPS estimate-$1.21
Valuation & ratios
Competitors
By market cap
By net margin
Profile
Rapport Therapeutics is a clinical-stage biotechnology company focused on developing small molecule precision medicines for neurological and psychiatric disorders. The company utilizes a proprietary RAP technology platform to target receptor-associated proteins (RAPs), enabling neuroanatomical specificity that aims to reduce the side effects common in traditional neuroscience drugs.
Competitive position
A clinical-stage innovator using a differentiated RAP-based platform to achieve regional brain specificity for validated CNS targets.
GeographiesUnited States, Global
Customer segmentsPatients, Healthcare providers
Business modelR&D-stage biotechnology, IP licensing
SuppliersContract Manufacturing Organizations (CMOs), Academic research institutions, Specialized laboratory equipment suppliers
CustomersClinical trial participants, Pharmaceutical distributors (future), Strategic commercial partners
CountryUnited States of America
Listed2024
CEOAbraham N. Ceesay
SectorHealthcare
IndustryBiotechnology
Websiterapportrx.com
FilingsSEC EDGAR
FAQ
- What is Rapport Therapeutics, Inc.'s market cap?
- Rapport Therapeutics, Inc. (RAPP) has a market capitalization of $2.2B and trades on NASDAQ.
- What is Rapport Therapeutics, Inc.'s revenue and profitability?
- Rapport Therapeutics, Inc. generated $20.0M in trailing twelve-month revenue with a net loss of $137.2M, representing a net margin of -685.8%, with free cash flow of -$97.1M. These figures are based on the Q2 2026 filing.
- Who are Rapport Therapeutics, Inc.'s competitors?
- Rapport Therapeutics, Inc.'s key competitors include Xenon Pharmaceuticals Inc., Praxis Precision Medicines, Inc., Biohaven Ltd., and others. These companies compete in similar markets and product categories.
- Who does Rapport Therapeutics, Inc. partner with?
- Rapport Therapeutics, Inc.'s notable partners include Janssen Pharmaceutical NV, NeuroPace, Inc., Third Rock Ventures, and others.
- Where is Rapport Therapeutics, Inc. headquartered?
- Rapport Therapeutics, Inc. is headquartered in United States of America. It has been publicly traded since 2024.
